They set an "overweight" rating and a $67.00 price target for the company. Oppenheimer Holdings, Inc. reissued an "outperform" rating on shares of Centene Corporation in a research report on Tuesday, December 20th. Sanford C. Bernstein raised Centene Corporation from a "market perform" rating to an "outperform" rating in a research report on Tuesday, January 31st. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company's stock. Centene Corporation now has an average rating of "Buy" and an average price target of $88.00.
Shares of Centene Corporation (NYSE:CNC) opened at 90.88 on Wednesday. Centene Corporation has a 52 week low of $50.00 and a 52 week high of $75.57. The company has a 50-day moving average of $84.56 and a 200-day moving average of $77.42.
Centene Corporation (NYSE:CNC) last announced its earnings results on Tuesday, July 25th. The company reported $1.19 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.11 by $0.08. Centene Corporation had a return on equity of 14.62% and a net margin of 1.72%. The company had revenue of $11.95 billion for the quarter, compared to analysts' expectations of $11.69 billion. During the same period in the prior year, the business posted $0.95 earnings per share. The business's quarterly revenue was up 89.0% on a year-over-year basis. Equities analysts anticipate that Centene Corporation will post $4.69 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: "Centene Corporation (NYSE:CNC) Shares Bought by Aviva PLC" was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece on another site, it was illegally copied and reposted in violation of worldwide copyright & trademark legislation. The correct version of this story can be accessed at https://weekherald.com/2017/09/13/centene-corporation-cnc-price-target-raised-to-107-00.html.
In other Centene Corporation news, EVP Jesse N. Hunter sold 5,000 shares of the stock in a transaction on Monday, February 13th. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Chairman Michael F. Neidorff sold 35,000 shares of Centene Corporation stock in a transaction on Thursday, July 6th. The stock was sold at an average price of $79.43, for a total value of $317,720.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 43,167 shares of company stock valued at $3,470,973.
A number of hedge funds have recently added to or reduced their stakes in the stock. Aviva PLC owned about 0.06% of Centene Corporation worth $8,418,000 as of its most recent SEC filing. IFP Advisors Inc now owns 1,944 shares of the company's stock valued at $155,000 after purchasing an additional 170 shares during the period. Ngam Advisors L.P. now owns 149,038 shares of the company's stock worth $10,637,000 after buying an additional 111,626 shares during the period. IFP Advisors Inc raised its stake in Centene Corporation by 9.6% during the 2nd quarter. Creative Planning now owns 2,476 shares of the company's stock worth $176,000 after buying an additional 127 shares during the period. Keybank National Association OH lifted its holdings in Centene Corporation by 1.1% in the second quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in Centene Corporation by 0.3% in the second quarter. The institutional investor owned 105,444 shares of the company's stock after purchasing an additional 1,980 shares during the period. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments.
Through Fidelis, Centene would purchase an established insurer in New York's Affordable Care Act, Medicaid and Medicare Advantage markets.